Goldman Sachs’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Sell |
199,386
-11,150
| -5% | -$123K | ﹤0.01% | 3351 |
|
|
2025
Q1 | $1.88M | Sell |
210,536
-14,567
| -6% | -$130K | ﹤0.01% | 3400 |
|
|
2024
Q4 | $2.12M | Sell |
225,103
-64,686
| -22% | -$609K | ﹤0.01% | 3437 |
|
|
2024
Q3 | $2.34M | Sell |
289,789
-43,762
| -13% | -$353K | ﹤0.01% | 3260 |
|
|
2024
Q2 | $2.83M | Buy |
333,551
+110,801
| +50% | +$940K | ﹤0.01% | 2989 |
|
|
2024
Q1 | $2M | Sell |
222,750
-63,541
| -22% | -$570K | ﹤0.01% | 3205 |
|
|
2023
Q4 | $3.22M | Buy |
286,291
+16,506
| +6% | +$186K | ﹤0.01% | 2900 |
|
|
2023
Q3 | $2.33M | Sell |
269,785
-70,814
| -21% | -$611K | ﹤0.01% | 3003 |
|
|
2023
Q2 | $3.53M | Buy |
340,599
+4,172
| +1% | +$43.2K | ﹤0.01% | 2816 |
|
|
2023
Q1 | $3.65M | Sell |
336,427
-9,556
| -3% | -$104K | ﹤0.01% | 2781 |
|
|
2022
Q4 | $3.88M | Sell |
345,983
-276,876
| -44% | -$3.11M | ﹤0.01% | 2819 |
|
|
2022
Q3 | $6.32M | Buy |
622,859
+39,830
| +7% | +$404K | ﹤0.01% | 2475 |
|
|
2022
Q2 | $5.28M | Sell |
583,029
-393,344
| -40% | -$3.56M | ﹤0.01% | 2608 |
|
|
2022
Q1 | $9.34M | Buy |
976,373
+632,582
| +184% | +$6.05M | ﹤0.01% | 2296 |
|
|
2021
Q4 | $3.8M | Buy |
343,791
+39,534
| +13% | +$437K | ﹤0.01% | 3025 |
|
|
2021
Q3 | $2.25M | Buy |
304,257
+16,498
| +6% | +$122K | ﹤0.01% | 3390 |
|
|
2021
Q2 | $4.18M | Buy |
287,759
+6,639
| +2% | +$96.4K | ﹤0.01% | 2913 |
|
|
2021
Q1 | $5.74M | Sell |
281,120
-68,389
| -20% | -$1.4M | ﹤0.01% | 2565 |
|
|
2020
Q4 | $6.21M | Buy |
349,509
+34,344
| +11% | +$610K | ﹤0.01% | 2352 |
|
|
2020
Q3 | $4.66M | Sell |
315,165
-18,780
| -6% | -$278K | ﹤0.01% | 2429 |
|
|
2020
Q2 | $7.01M | Buy |
333,945
+163,735
| +96% | +$3.44M | ﹤0.01% | 2144 |
|
|
2020
Q1 | $3.93M | Buy |
170,210
+53,562
| +46% | +$1.24M | ﹤0.01% | 2394 |
|
|
2019
Q4 | $3.02M | Sell |
116,648
-1,681
| -1% | -$43.5K | ﹤0.01% | 2717 |
|
|
2019
Q3 | $2.31M | Sell |
118,329
-126,889
| -52% | -$2.47M | ﹤0.01% | 2755 |
|
|
2019
Q2 | $4.01M | Sell |
245,218
-20,671
| -8% | -$338K | ﹤0.01% | 2413 |
|
|
2019
Q1 | $6.03M | Buy |
265,889
+31,071
| +13% | +$704K | ﹤0.01% | 2315 |
|
|
2018
Q4 | $6.01M | Buy |
234,818
+15,475
| +7% | +$396K | ﹤0.01% | 2203 |
|
|
2018
Q3 | $7.17M | Sell |
219,343
-3,182
| -1% | -$104K | ﹤0.01% | 2234 |
|
|
2018
Q2 | $5.05M | Sell |
222,525
-247,692
| -53% | -$5.62M | ﹤0.01% | 2399 |
|
|
2018
Q1 | $11.4M | Buy |
470,217
+272,599
| +138% | +$6.61M | ﹤0.01% | 1842 |
|
|
2017
Q4 | $5.51M | Sell |
197,618
-59,190
| -23% | -$1.65M | ﹤0.01% | 2249 |
|
|
2017
Q3 | $8.79M | Buy |
256,808
+17,632
| +7% | +$604K | ﹤0.01% | 2040 |
|
|
2017
Q2 | $9.53M | Sell |
239,176
-16,934
| -7% | -$675K | ﹤0.01% | 1954 |
|
|
2017
Q1 | $9.43M | Buy |
256,110
+198,062
| +341% | +$7.29M | ﹤0.01% | 1885 |
|
|
2016
Q4 | $1.85M | Buy |
58,048
+31,736
| +121% | +$1.01M | ﹤0.01% | 2763 |
|
|
2016
Q3 | $954K | Buy |
26,312
+10,430
| +66% | +$378K | ﹤0.01% | 3081 |
|
|
2016
Q2 | $360K | Buy |
15,882
+1,335
| +9% | +$30.3K | ﹤0.01% | 3536 |
|
|
2016
Q1 | $273K | Sell |
14,547
-4,288
| -23% | -$80.5K | ﹤0.01% | 3603 |
|
|
2015
Q4 | $309K | Buy |
18,835
+3,805
| +25% | +$62.4K | ﹤0.01% | 3498 |
|
|
2015
Q3 | $165K | Buy |
+15,030
| New | +$165K | ﹤0.01% | 3948 |
|
|
2014
Q3 | – | Sell |
-7,346
| Closed | -$234K | – | 4598 |
|
|
2014
Q2 | $234K | Buy |
+7,346
| New | +$234K | ﹤0.01% | 3873 |
|